Discontinued — last reported Q3 '25

Non-Current Assets

Intangibles (Net)

Humana Intangibles (Net) increased by 5.3% to $1.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.7%, from $1.43B to $1.19B. Over 3 years (FY 2022 to FY 2025), Intangibles (Net) shows a downward trend with a -13.9% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ3 2025

How to read this metric

High levels reflect significant investment in growth through acquisitions; changes indicate the impact of amortization or impairment charges.

Detailed definition

This includes the value of acquired intellectual property, such as patents, trademarks, and drug licenses, net of accumu...

Peer comparison

Very high in the pharmaceutical industry due to the reliance on patent-protected drug portfolios.

Metric ID: intangible_assets_net

Historical Data

13 periods
 Q4 '22Q1 '23Q2 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.77B$1.75B$1.78B$1.69B$1.68B$1.66B$1.65B$1.44B$1.43B$1.38B$1.23B$1.13B$1.19B
QoQ Change-0.6%+1.6%-5.0%-0.8%-1.0%-0.8%-12.5%-1.1%-3.3%-10.9%-8.3%+5.3%
YoY Change-4.1%-4.3%-6.7%-14.8%-15.0%-17.0%-25.5%-21.8%-16.7%
Range$1.13B$1.78B
CAGR-12.4%
Avg YoY Growth-14.0%
Median YoY Growth-15.0%

Intangibles (Net) at Other Companies

Frequently Asked Questions

What is Humana's intangibles (net)?
Humana (HUM) reported intangibles (net) of $1.19B in Q1 2026.
How has Humana's intangibles (net) changed year-over-year?
Humana's intangibles (net) decreased by 16.7% year-over-year, from $1.43B to $1.19B.
What is the long-term trend for Humana's intangibles (net)?
Over 3 years (2022 to 2025), Humana's intangibles (net) has grown at a -13.9% compound annual growth rate (CAGR), from $1.77B to $1.13B.
What does intangibles (net) mean?
The value of non-physical assets like patents and brand names, minus their amortized cost.